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RAPID COMMUNICATION 
Induction of Human Monocyte to Macrophage Maturation In Vitro 
by 1,25-Dihydroxyvitamin D, 
By Marina Kreutz and Reinhard Andreesen 
Cells of the mononuclear phagocyte system arise from 
circulating blood monocytes (MO) that undergo further 
maturation on leaving the vasculature and migration into 
the various tissues and body cavities. This terminal differ- 
entiation step is also observed in vitro when blood MO are 
cultured in the presence of serum. Yet, the inducing signals 
present in serum are not defined. We have established 
primary cultures from elutriation-purified blood MO and 
found that the active metabolite of vitamin D, 1.25- 
dihydroxyvitamin D, (1,25(OH),D,) could induce maturation 
of MO to macrophages (MAC) in the absence of any serum 
proteins. Cells were cultured for 7 days with AB-group 
serum or ,1 ,25(OH),D,, respectively, and MO maturation 
IRCULATING BLOOD monocytes (MO) provide a C common precursor pool which gives rise to the heterog- 
enous family of cells that constitute the human mononuclear 
phagocyte system (MPS).' The terminal differentiation of 
blood M O  to mature macrophages (MAC) can also be 
followed in Here, when cultured in the presence of 
serum M O  undergo a characteristic change in morphology, 
cytochemistry, and function, a process considered to be 
similar to the differentiation of M O  in vivo. M O  maturation 
in vitro is associated with the expression of specific antigens 
not found on blood M O  but present on Their 
analysis is used to more objectively define maturation in 
primary cultures of human hf0.9,'0 
No consistent knowledge presently exists on the regulation 
of M O  to MAC transformation. Serum needs to be present in 
M O  cultures for successful maturation into MAC, neither 
known hematopoietins nor other yet defined cytokines are 
able to replace serum. Only macrophage colony-stimulating 
factor (M-CSF) might be of importance as a competence and 
survival factor for M O  in vitro" (Brugger W, Kreutz M, 
Andreesen R: Macrophage colony-stimulating factor is re- 
quired for monocyte survival and acts as a cofactor for their 
terminal differentiation to macrophages in vitro. J Leukoc 
Biol, in press 199 1). 
The major biologically active metabolite of vitamin D,, 
1,25-dihydroxyvitamin D,-( 1 ,25(OH),D,), has found increas- 
ing attention since functional receptors have been found to be 
ubiquitous in tissue di~tr ibut ion. '~ . '~  Beside the classical role 
of 1,25 (OH), D, in mineral homeostasis this molecule was 
shown to be an immunoregulatory In addition, 
several studies using tumor cell lines16-18 as well as cultures of 
normal bone marrow precursors" have shown I ,25(OH),D, 
to induce cell differentiation toward the macrophage lineage. 
There is also preliminary evidence that 1,25(OH),D, sup- 
ports the serum-induced differentiation of blood MO.,' 
In this study, the effect of 1,25(OH),D, on the induction 
and promotion of terminal human M O  to MAC differentia- 
tion in serum-free culture was investigated. M O  were found 
to develop all the characteristics of mature MAC with 
1 ,25(OH),D, being the only additive to the culture medium. 
Successful terminal differentiation was shown not only by the 
analyzed by morphology, functional activity, and the expres- 
sion of lineage-restricted maturation-associated antigens 
(MAX.l, MAX.3). At an optimal concentration of IO-' 
mol/L, 1 ,25(OH),D, promoted the development of fully 
differentiated MAC whose phenotype and functional com- 
petence in terms of cytokine release (tumor necrosis factor 
a. interleukin-6, fibronectin, and lysozyme) was compara- 
ble with MAC grown in serum. In conclusion, our data may 
add to the immunoregulatory potential of 1,25(OH),D,. 
which may play an essential role in the ontogeny of the 
mononuclear phagocyte system. 
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expression of maturation-associated (MAX) antigens but 
also by the cytokine repertoire of 1,25(0H),D3-induced 
MAC. 
MATERIALS AND METHODS 
Peripheral blood mononuclear cells (MNC) were 
separated from leukapheresis products of healthy donors by density 
gradient centrifugation over Ficoll. MO were isolated from MNC by 
countercurrent centrifugal elutriation in a J6M-E centrifuge and a 
JE-5 rotor (Beckman, Miinchen, Germany) at 2,500 rpm with a 
standard chamber and a flow rate of 20 mL/min as previously 
described." Elutriated MO were of greater than 90% purity as 
estimated by morphology and expression of CD14 antigen. Purified 
MO were resuspended in RPMI 1640 (Biochrom, Berlin, Germany) 
supplemented with 5 x lo-' mol/L mercaptoethanol, vitamins, 
antibiotics, pyruvat, and nonessential amino acids. MO were cul- 
tured in 96-well microtiterplates (Greiner, Niirtingen, Germany) at 
2 x cells/0.2 mL supplemented RPMI 1640 with or without 5% 
AB-group serum or 1,25(OH),D, (Hoffmann-La Roche, Basel, 
Switzerland) at various concentrations. 1,25(OH),D, was dissolved 
in 100% ethanol to a stock concentration of 2- x lo-' mol/L and 
stored at -2OOC. The various concentrations were obtained by 
diluting the stock solution in RPMI 1640. After 7 days medium was 
removed and cells were cultured with fresh, serum-free supple- 
mented RPMI 1640 without or with 1 pg/mL lipopolysaccharide 
(LPS) (Salmonella abortus equi, kindly provided by C. Galanos, 
Max-Planck-Inst., Freiburg, Germany) for 24 hours. Supernatants 
were harvested and stored at -2OOC. 
MO culture. 
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Immunophenotype analysis. Subsequent to supernatant collec- 
tion cell monolayers were fixed with 0.05% glutaraldehyde and 
surface antigen expression was measured by cell enzyme-linked 
immunosorbent assay (ELISA) as described el~ewhere.'.'~ The 
following antibodies were used: anti-j32-microglobulin (Becton Dick- 
inson, Rodermark, Germany), MAX.1 and MAX.3 (own 
laboratory).' Optical density (OD) was measured at 492 nm, 
corrected by the OD of specificity controls, mean of triplicates. Data 
are given as antigen expression index (AEI), which was calculated 
by dividing the OD values of the respective antigen by the OD value 
for 02-microglobulin expression times 100. 
Supernatants were pooled from 15 individ- 
ual wells and tested for tumor necrosis factor a (TNFa) by ELISA 
(T Cell Science, Inc, Cambridge, MA). Fibronectin was also 
determined by ELISA (own development). Lysozyme was measured 
photometrically (Behringwerke, Marburg, Germany). Interleukin-6 
(IL-6) activity was tested in a bioassay using the IL-6-dependent 
cell line B9 (kindly provided by Dr Aarden, Amsterdam, The 
Netherlands)." 
Functional analysis. 
RESULTS 
The in vitro differentiation of circulating blood MO to 
MAC occurs in the presence of serum and can be followed by 
the expression of maturation-associated antigens of the 
MAX series that are absent on blood MO but expressed on 
terminally differentiated MAC. As shown in Fig 1, 
1,25(OH),D3 can substitute for serum to promote the differ- 
entiation of MO into MAC as determined by the expression 
of MAX.1 and MAX.3 antigens. In the range of 1 to 100 
nmol/L 1 ,25(OH),D3 MAX antigen expression was compa- 
rable with that of serum-derived MAC. There was no 
maturation in the absence of serum or 1,25(OH),D3. This 
result was also evident from morphology: in serum-free 
cultures cells stayed monocytoid in morphology, whereas 
MO treated with serum or 1,25(OH),D, became larger, 
more spread, and developed macrophage-typical morphology 
(not shown). 
These phenotypic and morphologic changes taking place 
during the maturation from MO into MAC are accompanied 
by characteristic changes in the biosecretory repertoire of the 
cell. MO were cultured for 7 days with or without serum or 
1 ,25(OH),D3 and day-7 supernatants analyzed for the follow- 
AEI (%) 
120 
100 
80 
60 
40 
20 
0 
i% + MAX.l 
ing secretory products: lysozyme, fibronectin, IL-6, and 
TNFa. 
As shown in Fig 2, 1,25(OH),D3-induced MAC produce 
large amounts of IL-6 when stimulated with LPS. The 
secretion is about sixfold higher than serum-derived MAC. 
TNFa, which increases 10-fold on MO to MAC maturation, 
is in the same range in serum and 1,25(0H),D3-induced 
MAC (Fig 2). Lysozyme and fibronectin are secreted consti- 
tutively in similar amounts by 1,25(OH),D3- and serum- 
induced MAC, respectively (Fig 3). The optimal dose of 
1 ,25(OH),D3 to induce functionally competent MAC in 
terms of cytokine release was 1 to 100 nmol/L 1,25(OH),D3, 
which is similar to what was observed for the expression of 
maturation-associated antigen. 
Thus, from phenotypic and functional analysis 
1 ,25(0H),D3-induced MAC resemble mature serum-de- 
rived MAC. 
DISCUSSION 
The in vitro maturation of blood MO into MAC is a useful 
model to study regulatory signals and functional conse- 
quences of this differentiation process, which seems to be 
central in the ontogeny of the MAC cell system.' Factors 
present in serum and responsible for this differentiation- 
inducing activity have not been identified yet. There have 
been reports implicating M-CSF," IL-4,,, and human gamma 
globulins23 as possible mediators for MAC differentiation. 
However, none of these substances had the capacity to induce 
MAC differentiation in our culture system comparable with 
serum though M-CSF proved to be essential for MO survival 
in vitro. 
Our results presented here clearly show that the active 
metabolite of vitamin D3, 1 ,25(OH),D3, induces terminal 
differentiation of circulating blood MO to mature MAC in 
vitro. Macrophages developing in the presence of 
1,25(OH),D, expressed maturation-associated antigens and 
secreted lysozyme and fibronectin with the latter being 
restricted specifically to MAC at differentiation stages be- 
yond the blood MO In addition, the functional 
competence of 1,25(0H),D3-induced MAC is shown by their 
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Fig 1. Induction of MO to MAC maturation by 
1,25(0H),D,. Elutriated MO were cultured with 
125(OH),D, for 7 days in microtiterplates. Matura- 
tion is analyzed by the expression of MAX.1 and 
MAX.3 antigens given as AEI, mean of triplicate 
values, SD 4 5 % .  Data are from one representa- 
tive experiment out of three. 
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Fig 2. LPS-induced secretion of IL-6 and TNFa 
in 1 ,25(OH),D3-induced MAC. MO were cultured 
for 7 days with serum or 1 ,25(OH),D,, respectively. 
Medium was removed and MAC were cultured for 
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-11 24 hours with fresh medium containing 1 pg/mL 
LPS abortus equi. Supernatants were then tested 
for cytokines. 
cytokine repertoire, eg, high release of TNFa and IL-6 and 
the absence of IL-lP (not shown) a feature common to 
successful MO to MAC differentiation in ~itro.~~*~'-Although 
1,25(OH),D3 has been long known as an inducer of mono- 
cytic differentiati~n'~-~' and osteoclast generation:' most 
published work was concerned with the differentiation of 
tumor cell lines and early hematopoietic precursor cells. 
There are some lines of evidence that MO to MAC differen- 
tiation is differently regulated than monocytic differentiation 
of tumor cell lines. First, the differentiation induced in tumor 
cell lines seems not to proceed beyond the blood MO stage 
(unpublished observation). Secondly, the differentiation- 
inducing stimulant for tumor cells, interferon-y (IFNy), has 
opposite effects on blood MO, eg, suppresses serum-induced 
maturation to MAC." In comparison with serum-containing 
cultures 1,25(OH),D3-induced MAC maturation resulted in 
a considerable smaller cell recovery (20% to 40% of serum- 
induced MAC). Additional factors may be present in serum 
to promote cell survival. Studies are in progress to identify 
those cofactors that might be present in the albumin fraction 
as shown by preliminary experiments. 
It should be noted that the effects observed in our system 
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are in a dose range about 10- to 100-fold higher than 
measured in the AB-group sera used in our experiments 
(mean of six different donors 1.1 x lo-'' mol/L, SD = 5 x 
lo-" mol/L; measured by Limbach, Schmidt-Gayk, Heidel- 
berg, Germany). This level of 1,25(OH),D3 is comparable 
with serum levels reported by other groups (1 x lo-'' 
m ~ l / L ) . * ~  Yet it should be noted that this is an effect induced 
by 1,25(OH),D3 alone in serum-free culture, whereas in 
serum other synergistic factors have to be discussed that may 
potentiate the effect of 1,25(OH),D3. It should also be 
mentioned that for all in vitro activities attributed to 
1,25(OH),D,, a similar dose is rep~rted.".'~ The negative 
effect of high doses of 1,25(OH),D3 most likely relates to an 
unspecific membrane effect because secosteroids like 
1 ,25(OH),D3 are highly lipophilic substances. According to 
this finding is the observation that high doses of the metabo- 
lite 25(OH)D3 were found to be toxic for MO, too (data not 
shown in detail). 
Elevated serum levels of 1,25(OH),D, have been shown in 
diseases such as sarcoidosis and macrophages associated with 
granuloma tissue secrete 1,25(OH),D3 in vitro.30 It is conceiv- 
able that MAC-derived 1,25(OH),D3 may serve as an 
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Fig 3. Constitutive secretion of lysozyme and 
fibronectin by 1,25(0H),D,-induced MAC. For de- 
tails see legend to Fig 2. Supernatants were 
generated without the addition of stimuli. 
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autocrine signal to promote MO to MAC generation and  
may even be implicated in the pathophysiology of this 
chronic inflammatory reaction by inducing tha t  type of 
MAC characteristic of a granulomatous inflammation. 
Chronic bacterial infection may support this autoregulatory 
circuit as LPS are potent stimuli of vitamin D 3  metaboli~m.~’ 
Similarly, IFNy stimulates the synthesis of 1 ,25(OH),D3 in 
normal human MAC3’ It should also be noted tha t  MAC 
obtained from vitamin D3-deficient mice showed an im- 
paired response to activation for tumor cy to t~xic i ty . ’~  In view 
of our data this functional defect might well be related to 
incomplete MO maturation as both the spontaneous and 
IFNy-activated tumor cytotoxicity depend crucially on a 
successful differentiation of blood MO to mature MAC.34 
I n  conclusion, t h e  ac t ive  v i tamin  D 3  me tabo l i t e  
1 ,25(OH),D3 appears to participate in the regulation of 
MAC ontogeny not only at the  level of committed stem cells 
but also as inducer of normal MO to MAC maturation. 
Especially the latter activity, through the multifold interac- 
tions of the MPS with other cell systems, may have wide- 
spread implications for normal homeostasis as well as to 
understand the  pathophysiology of abnormal vitamin D 3  
metabolism as it is seen in granulomatous disorders, he- 
matopoietic neoplasia, and chronic renal failure. 
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